The award recognizes Riverview Hospital's commitment and success in implementing a higher standard of care for heart attack patients, and signifies that Riverview Hospital has reached an aggressive goal of treating coronary artery disease patients with an outstanding level of compliance to core standard levels of care outlined by the American College of Cardiology/American Heart Association clinical guidelines and recommendations.
To receive the ACTION Registry–GWTG Gold Performance Achievement Award, Riverview Hospital consistently followed the treatment guidelines in ACTION Registry–GWTG for 24 consecutive months. These include aggressive use of medications like cholesterol-lowering drugs, beta-blockers, ACE inhibitors, aspirin, and anticoagulants in the hospital.
"The American College of Cardiology Foundation and the American Heart Association commend Riverview Hospital for its success in implementing standards of care and protocols. The full implementation of acute and secondary prevention guideline-recommended therapy is a critical step in saving the lives and improving outcomes of heart attack patients,” Gregg C. Fonarow, MD, ACTION Registry- GWTG Steering Committee Chairperson and Director of Ahmanson-UCLA Cardiomyopathy Center.
“The time is right for Riverview Hospital to be focused on improving the quality of cardiovascular care by implementing ACTION Registry–GWTG. The number of acute myocardial infarction patients eligible for treatment is expected to grow over the next decade due to increasing incidence of heart disease and a large aging population,” said Pat Fox, Riverview Hospital CEO.
